Alison Moore, Chief Technical Officer at Allogene Therapeutics, Inc. (ALLO), sold 97,654 shares at $29.18 ($2.9M) on 2019-07-26, disclosed to the SEC on 2019-07-30.
Open-market sale of $2.9M ALLO by Chief Technical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.18 | 13,193 | $385K | 13.4% |
| 2 | $29.18 | 13,193 | $385K | 13.4% |
| 3 | $29.39 | 23,815 | $700K | 24.3% |
| 4 | $29.39 | 23,815 | $700K | 24.3% |
| 5 | $29.84 | 11,819 | $353K | 12.3% |
| 6 | $29.85 | 11,819 |
| $353K |
| 12.3% |
| Total | $29.44 avg | 97,654 | $2.9M | 100% |
| Filing → |
| CDXS | SELL | 2025-10-15 | $16K | — | Filing → |
| ALLO | SELL | 2022-03-17 | $133K | — | Filing → |
| ALLO | SELL | 2021-03-17 | $470K | — | Filing → |